Literature DB >> 23370086

Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review.

Gustavo Fabregat1, José De Andrés, Vicente L Villanueva-Pérez, Juan M Asensio-Samper.   

Abstract

OBJECTIVE: Botulinum toxin is a neurotoxin that has been widely used in chronic pain for the treatment of multiple conditions with a component of localized muscle spasm. Recent studies suggest that botulinum toxin is effective in the treatment of neuropathic pain syndromes such as postherpetic neuralgia or painful scars.
METHODS: We searched the PubMed and OvidSP databases. We also included cross-referencing bibliographies from primary and review articles. DISCUSSION: In this descriptive review, we evaluate the usefulness, safety, and potential pathophysiological mechanism of botulinum toxin type A for treatment of painful disorders with neuropathic component such as postherpetic neuralgia, diabetic neuropathy, or trigeminal neuralgia.
CONCLUSIONS: On the basis of the analysis of the reports published in the literature, it would seem that fractioned peripheral subcutaneous and perineural injections of botulinum toxin type A may be useful for the treatment of various chronic pain conditions with neuropathic component.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370086     DOI: 10.1097/AJP.0b013e31827eafff

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  10 in total

1.  Comparative functional analysis of mice after local injection with botulinum neurotoxin A1, A2, A6, and B1 by catwalk analysis.

Authors:  Molly S Moritz; William H Tepp; Heather N'te Inzalaco; Eric A Johnson; Sabine Pellett
Journal:  Toxicon       Date:  2019-06-07       Impact factor: 3.033

2.  Update on Interventional Management of Neuropathic Pain: A Delphi Consensus of the Spanish Pain Society Neuropathic Pain Task Force.

Authors:  Ancor Serrano-Afonso; Rafael Gálvez; Elena Paramés; Ana Navarro; Dolores Ochoa; Concepción Pérez-Hernández
Journal:  Medicina (Kaunas)       Date:  2022-04-30       Impact factor: 2.948

Review 3.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 4.  Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.

Authors:  Domenico Intiso; Mario Basciani; Andrea Santamato; Marta Intiso; Filomena Di Rienzo
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

5.  Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.

Authors:  Shuang Li; Ya-Jun Lian; Yuan Chen; Hai-Feng Zhang; Yun-Qing Ma; Cai-Hong He; Chuan-Jie Wu; Nan-Chang Xie; Ya-Ke Zheng; Yi Zhang
Journal:  J Headache Pain       Date:  2014-06-22       Impact factor: 7.277

6.  Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.

Authors:  Zee-A Han; Dae Heon Song; Hyun-Mi Oh; Myung Eun Chung
Journal:  Ann Neurol       Date:  2016-02-16       Impact factor: 10.422

7.  A new treatment for frostbite sequelae; Botulinum toxin.

Authors:  Arne Johan Norheim; James Mercer; Frauke Musial; Louis de Weerd
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

8.  Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome.

Authors:  Yongki Lee; Chul Joong Lee; Eunjoo Choi; Pyung Bok Lee; Ho-Jin Lee; Francis Sahngun Nahm
Journal:  Toxins (Basel)       Date:  2018-04-19       Impact factor: 4.546

9.  Factors affecting the therapeutic effect of botulinum toxin A on trigeminal neuralgia: A follow-up retrospective study of 152 patients.

Authors:  Haifeng Zhang; Yajun Lian; Nanchang Xie; Xuan Cheng; Chen Chen; Hongliang Xu; Yake Zheng
Journal:  Exp Ther Med       Date:  2019-09-09       Impact factor: 2.447

10.  Ultrasound-guided peripheral nerve interventions for common pain disorders.

Authors:  B P Krishna Prasad; Binu Joy; Vijayakumar A Raghavendra; Ajith Toms; Danny George; Brijesh Ray
Journal:  Indian J Radiol Imaging       Date:  2018 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.